TipRanks
Concord Biotech Ltd. (IN:CONCORDBIO)
:CONCORDBIO
India Market
CONCORDBIO
Concord Biotech Ltd.
RESEARCH TOOLSreports
Want to see IN:CONCORDBIO full AI Analyst Report?

Concord Biotech Ltd. (CONCORDBIO) Ratios

4 Followers

Concord Biotech Ltd. Ratios

IN:CONCORDBIO's free cash flow for Q1 2027 was ₹0.41. For the 2027 fiscal year, IN:CONCORDBIO's free cash flow was decreased by ₹ and operating cash flow was ₹0.25. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Mar 24Mar 23
Liquidity Ratios
Current Ratio
 0.00 7.39 6.17 6.30 3.79
Quick Ratio
 0.00 5.46 4.87 4.84 2.69
Cash Ratio
 0.00 0.08 <0.01 0.11 0.02
Solvency Ratio
 -0.17 1.53 1.92 2.07 1.31
Operating Cash Flow Ratio
 0.00 1.59 1.34 1.87 1.28
Short-Term Operating Cash Flow Coverage
 0.00 0.00 649.20 42.61 9.84
Net Current Asset Value
₹ 20.15B₹ 10.31B₹ 9.14B₹ 7.22B₹ 5.04B
Leverage Ratios
Debt-to-Assets Ratio
 0.00 <0.01 <0.01 <0.01 0.02
Debt-to-Equity Ratio
 0.00 <0.01 <0.01 <0.01 0.02
Debt-to-Capital Ratio
 0.00 <0.01 <0.01 <0.01 0.02
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 <0.01
Financial Leverage Ratio
 0.00 1.11 1.12 1.11 1.17
Debt Service Coverage Ratio
 1.28K 1.18K 273.97 35.71 7.93
Interest Coverage Ratio
 1.20K 1.03K 577.89 166.74 56.71
Debt to Market Cap
 0.00 0.00 <0.01 <0.01 <0.01
Interest Debt Per Share
 0.02 0.25 0.38 1.23 3.89
Net Debt to EBITDA
 0.00 -0.03 <0.01 -0.01 0.08
Profitability Margins
Gross Profit Margin
51.07%41.87%64.03%65.61%77.49%
EBIT Margin
31.61%32.70%38.34%38.03%35.15%
EBITDA Margin
38.36%39.76%42.72%43.13%41.33%
Operating Profit Margin
28.29%27.77%50.16%51.26%60.71%
Pretax Profit Margin
32.86%32.67%41.21%40.57%37.74%
Net Profit Margin
24.80%24.73%30.97%30.30%28.14%
Continuous Operations Profit Margin
24.62%24.57%30.97%30.30%28.14%
Net Income Per EBT
75.46%75.70%75.15%74.68%74.56%
EBT Per EBIT
116.15%117.65%82.15%79.15%62.17%
Return on Assets (ROA)
0.00%11.68%18.27%18.12%15.86%
Return on Equity (ROE)
14.30%12.93%20.50%20.18%18.61%
Return on Capital Employed (ROCE)
0.00%14.18%32.54%33.44%39.18%
Return on Invested Capital (ROIC)
0.00%10.66%24.42%24.85%28.66%
Return on Tangible Assets
0.00%11.68%18.28%18.12%15.86%
Earnings Yield
1.92%2.43%2.14%1.98%2.43%
Efficiency Ratios
Receivables Turnover
 0.00 2.29 2.30 2.91 2.73
Payables Turnover
 0.00 6.02 3.82 3.70 2.05
Inventory Turnover
 0.00 1.88 1.80 1.68 0.90
Fixed Asset Turnover
 0.00 1.22 1.42 1.29 1.11
Asset Turnover
 0.00 0.47 0.59 0.60 0.56
Working Capital Turnover Ratio
 2.05 1.04 1.41 1.58 1.68
Cash Conversion Cycle
 0.00 292.82 265.71 243.95 359.08
Days of Sales Outstanding
 0.00 159.23 158.66 125.48 133.87
Days of Inventory Outstanding
 0.00 194.25 202.63 217.02 403.45
Days of Payables Outstanding
 0.00 60.66 95.57 98.55 178.24
Operating Cycle
 0.00 353.48 361.28 342.50 537.32
Cash Flow Ratios
Operating Cash Flow Per Share
 14.44 25.58 23.65 25.38 23.51
Free Cash Flow Per Share
 9.33 16.54 13.02 17.18 9.65
CapEx Per Share
 5.11 9.04 10.63 8.19 13.87
Free Cash Flow to Operating Cash Flow
 0.65 0.65 0.55 0.68 0.41
Dividend Paid and CapEx Coverage Ratio
 0.91 1.30 1.22 1.69 1.24
Capital Expenditure Coverage Ratio
 2.82 2.83 2.23 3.10 1.70
Operating Cash Flow Coverage Ratio
 0.00 116.29 83.32 27.26 7.80
Operating Cash Flow to Sales Ratio
 0.14 0.26 0.21 0.26 0.29
Free Cash Flow Yield
0.68%1.62%0.78%1.15%1.02%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 52.16 41.10 46.82 50.53 41.08
Price-to-Sales (P/S) Ratio
 12.92 10.16 14.50 15.31 11.56
Price-to-Book (P/B) Ratio
 7.11 5.32 9.60 10.20 7.65
Price-to-Free Cash Flow (P/FCF) Ratio
 146.74 61.58 127.69 86.60 97.74
Price-to-Operating Cash Flow Ratio
 94.78 39.82 70.31 58.65 40.09
Price-to-Earnings Growth (PEG) Ratio
 -2.28 -1.36 2.27 1.78 1.10
Enterprise Value Multiple
 33.68 25.54 33.93 35.49 28.05
Enterprise Value
 143.20B 107.11B 173.98B 155.63B 98.91B
EV to EBITDA
 33.68 25.54 33.93 35.49 28.05
EV to Sales
 12.92 10.15 14.50 15.30 11.59
EV to Free Cash Flow
 146.74 61.51 127.71 86.57 98.01
EV to Operating Cash Flow
 94.78 39.78 70.32 58.63 40.21
Tangible Book Value Per Share
 192.62 191.22 173.17 145.90 123.29
Shareholders’ Equity Per Share
 192.62 191.57 173.27 145.93 123.31
Tax and Other Ratios
Effective Tax Rate
 0.25 0.25 0.25 0.25 0.25
Revenue Per Share
 105.95 100.19 114.71 97.21 81.55
Net Income Per Share
 26.27 24.78 35.52 29.45 22.95
Tax Burden
 0.75 0.76 0.75 0.75 0.75
Interest Burden
 1.04 1.00 1.07 1.07 1.07
Research & Development to Revenue
 0.00 0.00 0.02 0.02 0.04
SG&A to Revenue
 0.11 0.14 0.12 0.00 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.47 1.03 0.67 0.86 1.02
Currency in INR